These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 11043845)
1. Male breast cancer. Does the prognosis differ compared to female? Herman K; Lobaziewicz W; Skotnicki P; Fortuna J; Kusy T; Leśniak T Neoplasma; 2000; 47(3):191-5. PubMed ID: 11043845 [TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of resectable breast cancer: a report of 6 263 cases]. Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535 [TBL] [Abstract][Full Text] [Related]
3. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [TBL] [Abstract][Full Text] [Related]
4. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306 [TBL] [Abstract][Full Text] [Related]
5. Differences between male and female breast cancer. III. Prognostic features. Rudan I; Rudan N; Basić N; Basić V; Rudan D; Jambrisak Z Acta Med Croatica; 1997; 51(3):135-41. PubMed ID: 9248110 [TBL] [Abstract][Full Text] [Related]
6. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Di Saverio S; Gutierrez J; Avisar E Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874 [TBL] [Abstract][Full Text] [Related]
7. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650 [TBL] [Abstract][Full Text] [Related]
8. Male breast cancer in the veterans affairs population: a comparative analysis. Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768 [TBL] [Abstract][Full Text] [Related]
9. Breast cancer prognosis. I. Prognostic factors in patients with node-negative (N0) breast cancer. Rudan I; Skorić T; Rudan N Acta Med Croatica; 1994; 48(4-5):159-63. PubMed ID: 7534517 [TBL] [Abstract][Full Text] [Related]
10. Recurrence in breast cancer. Analysis with frailty model. Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450 [TBL] [Abstract][Full Text] [Related]
11. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer. Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189 [TBL] [Abstract][Full Text] [Related]
12. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335 [TBL] [Abstract][Full Text] [Related]
13. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy. Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422 [TBL] [Abstract][Full Text] [Related]
14. Breast cancer prognosis. II. Prognostic factors in patients with node-positive (N1-3) breast cancer. Rudan I; Skorić T; Rudan N Acta Med Croatica; 1994; 48(4-5):165-70. PubMed ID: 7534518 [TBL] [Abstract][Full Text] [Related]
15. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891 [TBL] [Abstract][Full Text] [Related]
16. Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival. Grabau D; Jensen MB; Rank F; Blichert-Toft M APMIS; 2007 Jul; 115(7):828-37. PubMed ID: 17614850 [TBL] [Abstract][Full Text] [Related]
17. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091 [TBL] [Abstract][Full Text] [Related]
18. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262 [TBL] [Abstract][Full Text] [Related]
19. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women. Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882 [TBL] [Abstract][Full Text] [Related]
20. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods. Skowronek J; Piotrowski T Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]